Skip to main content

Table 3 Univariate survival analysis (Kaplan-Meier) in selected subgroups of patients with NEC of the breast according to characteristics

From: Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database

Characteristics

5-year DSS

5-year OS

n

Survival rate (95% CI)

HR (95% CI)

P

Survival rate (95% CI)

HR (95% CI)

P

Sex

   

NS

  

NS

 Male

2

Not reached

  

Not reached

  

 Female

133

66.2 (54.2-75.7)

Not reached

 

54.1 (42.7-64.3)

0.39 (0.05-2.84)

 

Age (year)

   

NS

  

NS

 ≤60

55

67.9 (43.0-83.8)

  

59.1 (37.6-75.4)

  

 >60

80

63.7 (49.2-75.1)

1.56 (0.74-3.32)

 

49.5 (35.8-61.8)

1.58 (0.85-2.91)

 

Race

   

0.031

  

NS

 White

114

68.9 (55.4-78.9)

  

55.4 (42.8-66.4)

  

 Black

13

63.3 (28.6-84.6)

1.63 (0.56-4.70)

 

58.0 (26.1-80.2)

1.27 (0.50-3.25)

 

 Other

8

Not reached

3.15 (1.08-9.19)

 

Not reached

2.39 (0.94-6.11)

 

AJCC TNM stage

   

<0.0001

  

<0.0001

 I

32

84.3 (43.2-96.6)

  

74.4 (43.4-90.0)

  

 II

49

82.6 (64.4-92.0)

2.14 (0.44-10.4)

 

73.9 (56.3-85.3)

1.15 (0.42-3.14)

 

 III

16

58.2 (21.0-82.8)

5.75 (1.05-31.5)

 

42.2 (14.3-68.2)

3.26 (1.09-9.75)

 

 IV

32

20.7 (5.70-42.1)

18.0 (4.14-78.6)

 

17.1 (4.72-35.9)

6.92 (2.78-17.2)

 

LN

   

NS

  

NS

 Negative

52

84.2 (58.1-94.7)

  

72.8 (49.6-86.7)

  

 Positive

38

72.1 (48.8-86.1)

2.93(0.87-9.81)

 

62.7 (41.8-77.9)

1.96 (0.82-4.68)

 

Size (mm)

   

<0.0001

  

0.002

 ≤20

73

81.8 (65.1-90.9)

  

67.9 (52.1-79.5)

  

 >20

48

53.4 (34.7-68.9)

4.82 (2.08-11.2)

 

44.4 (27.7-59.9)

2.70 (1.45-5.03)

 

Grade

   

NS

  

NS

 I

15

77.8 (31.6-94.7)

  

70.0 (29.9-90.0)

  

 II

29

74.2 (41.3-90.4)

1.12 (0.22-5.78)

 

59.6 (31.6-79.3)

1.18 (0.31-4.46)

 

 III

58

68.0 (51.0-80.2)

2.09 (0.47-9.28)

 

54.3 (38.9-67.3)

2.39 (0.72-7.98)

 

ER status

   

NS

  

0.01

 Negative

36

Not reached

  

Not reached

  

 Positive

72

66.0 (49.7-78.1)

0.85 (0.58-1.26)

 

64.8 (48.7-77.0)

0.65 (0.47-0.90)

 

PR status

   

NS

  

0.022

 Negative

58

60.8 (40.3-76.2)

  

45.6 (27.8-61.7)

  

 Positive

48

71.8 (53.3-84.0)

0.78 (0.52-1.15)

 

71.8 (53.3-84.0)

0.66 (0.46-0.94)

 

Radiation

   

NS

  

NS

 No

85

69.5 (54.1-80.6)

  

50.2 (35.4-63.2)

  

 Yes

50

62.0 (41.8-76.9)

1.10 (0.55-2.21)

 

58.3 (39.0-73.4)

0.75 (0.42-1.36)

 

Surgery

   

0.003

  

0.012

 No

28

40.6 (17.6-62.6)

  

34.6 (14.9-55.3)

  

 Yes

107

73.2 (59.7-82.8)

0.34 (0.16-0.69)

 

58.9 (45.9-69.9)

0.45 (0.25-0.84)

 
  1. Data from the Surveillance, Epidemiology and End Results Program, 2003 to 2009. NEC, neuroendocrine carcinoma; DSS, disease-specific survival; OS, overall survival; n, number of cases; HR, hazard ratio; NS, not significant; CI, confidence interval; TNM, tumor-lymph nodes-metastasis; LN, lymph node; ER, estrogen receptor; PR, progesterone receptor.